Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

1.

How does the nephrologist manage an LVAD patient on chronic maintenance dialysis?

Patel AM, Eduardo Rame J, Rudnick MR.

Semin Dial. 2014 May-Jun;27(3):284-8. doi: 10.1111/sdi.12229. Epub 2014 Mar 21. No abstract available.

PMID:
24650366
2.

Renal failure in patients with left ventricular assist devices.

Patel AM, Adeseun GA, Ahmed I, Mitter N, Rame JE, Rudnick MR.

Clin J Am Soc Nephrol. 2013 Mar;8(3):484-96. doi: 10.2215/CJN.06210612. Epub 2012 Oct 11. Review.

3.

Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.

Rudnick MR, Davidson C, Laskey W, Stafford JL, Sherwin PF; VALOR Trial Investigators.

Am Heart J. 2008 Oct;156(4):776-82.

PMID:
18946896
4.

Clinical significance and preventive strategies for contrast-induced nephropathy.

Sterling KA, Tehrani T, Rudnick MR.

Curr Opin Nephrol Hypertens. 2008 Nov;17(6):616-23. doi: 10.1097/MNH.0b013e32830f45a3. Review.

PMID:
18941356
5.

Contrast-induced nephropathy: is the picture any clearer?

Rudnick MR, Goldfarb S, Tumlin J.

Clin J Am Soc Nephrol. 2008 Jan;3(1):261-2. Epub 2007 Dec 12. Review. No abstract available.

6.

Contrast-induced nephropathy: how it develops, how to prevent it.

Rudnick MR, Kesselheim A, Goldfarb S.

Cleve Clin J Med. 2006 Jan;73(1):75-80, 83-7. Review.

PMID:
16444919
7.

Hemodialysis-related venous stenosis: treatment with ultrahigh-pressure angioplasty balloons.

Trerotola SO, Stavropoulos SW, Shlansky-Goldberg R, Tuite CM, Kobrin S, Rudnick MR.

Radiology. 2004 Apr;231(1):259-62.

PMID:
15068951
8.
9.

Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism.

Wang A, Holcslaw T, Bashore TM, Freed MI, Miller D, Rudnick MR, Szerlip H, Thames MD, Davidson CJ, Shusterman N, Schwab SJ.

Kidney Int. 2000 Apr;57(4):1675-80.

10.

Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease.

Berns JS, Rudnick MR, Cohen RM, Bower JD, Wood BC.

Kidney Int. 1999 Jul;56(1):253-60.

11.

Bromfenac disposition in patients with impaired kidney function.

Ermer JC, Boni JP, Cevallos WH, DeCleene S, Burghart P, Rudnick MR, Fruncillo RJ, Berns JS, Cohen RM.

Clin Pharmacol Ther. 1997 Mar;61(3):312-8.

PMID:
9084456
12.

Contrast media-associated nephrotoxicity.

Rudnick MR, Berns JS, Cohen RM, Goldfarb S.

Semin Nephrol. 1997 Jan;17(1):15-26. Review.

PMID:
9000546
13.

Contrast media-associated nephrotoxicity.

Rudnick MR, Berns JS, Cohen RM, Goldfarb S.

Curr Opin Nephrol Hypertens. 1996 Mar;5(2):127-33. Review.

PMID:
8744533
14.

Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients.

Berns JS, Haghighat A, Staddon A, Cohen RM, Schmidt R, Fisher S, Rudnick MR, Tomaszewski JE.

Cancer. 1995 Aug 1;76(3):497-500.

PMID:
8625132
15.

Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients.

Revicki DA, Brown RE, Feeny DH, Henry D, Teehan BP, Rudnick MR, Benz RL.

Am J Kidney Dis. 1995 Apr;25(4):548-54.

PMID:
7702049
16.

Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study.

Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, VanFossen DB.

Kidney Int. 1995 Jan;47(1):254-61.

PMID:
7731155
17.

Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.

Roth D, Smith RD, Schulman G, Steinman TI, Hatch FE, Rudnick MR, Sloand JA, Freedman BI, Williams WW Jr, Shadur CA, et al.

Am J Kidney Dis. 1994 Nov;24(5):777-84.

PMID:
7977319
18.

Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism--a critical review.

Rudnick MR, Berns JS, Cohen RM, Goldfarb S.

Am J Kidney Dis. 1994 Oct;24(4):713-27. Review.

PMID:
7942832
19.

Low-osmolality contrast media and the risk of contrast-associated nephrotoxicity.

Goldfarb S, Spinler S, Berns JS, Rudnick MR.

Invest Radiol. 1993 Nov;28 Suppl 5:S7-10; discussion S11-2. Review.

PMID:
8282507
20.

Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. The Iohexol Cooperative Study.

Hill JA, Winniford M, Cohen MB, Van Fossen DB, Murphy MJ, Halpern EF, Ludbrook PA, Wexler L, Rudnick MR, Goldfarb S.

Am J Cardiol. 1993 Oct 1;72(11):770-5.

PMID:
8213508
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk